Answer
The selected products are licensed for people aged 2 years and over with cystic fibrosis and at least one F508del CFTR mutation, using the age-appropriate formulation.
Sources for this answer
- Kaftrio 60 mg / 40 mg / 80 mg granules in sachet — Current selected SmPCemc · Summary of Product Characteristics
- Kaftrio 75 mg/50 mg/100 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics